0001785495-26-000003.txt : 20260126 0001785495-26-000003.hdr.sgml : 20260126 20260126165427 ACCESSION NUMBER: 0001785495-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260126 DATE AS OF CHANGE: 20260126 EFFECTIVENESS DATE: 20260126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vinci Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001785495 ORGANIZATION NAME: EIN: 842540421 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-571185 FILM NUMBER: 26561140 BUSINESS ADDRESS: STREET 1: 12 WASHINGTON AVENUE CITY: AVON BY THE SEA STATE: NJ ZIP: 07717 BUSINESS PHONE: 914-582-8305 MAIL ADDRESS: STREET 1: 12 WASHINGTON AVENUE CITY: AVON BY THE SEA STATE: NJ ZIP: 07717 D 1 primary_doc.xml X0708 D LIVE 0001785495 Vinci Pharmaceuticals, Inc. 12 Washington Avenue Avon by the Sea NJ NEW JERSEY 07717 914-582-8305 DELAWARE None None Corporation true Philip Gioia c/o Vinci Pharmaceuticals, Inc. 12 Washington Avenue Avon by the Sea NJ NEW JERSEY 07717 Executive Officer Director Sarah Hassan c/o Vinci Pharmaceuticals, Inc. 12 Washington Avenue Avon by the Sea NJ NEW JERSEY 07717 Director Sigurd Kirk c/o Vinci Pharmaceuticals, Inc. 12 Washington Avenue Avon by the Sea NJ NEW JERSEY 07717 Director Richard Lindstrom c/o Vinci Pharmaceuticals, Inc. 12 Washington Avenue Avon by the Sea NJ NEW JERSEY 07717 Director Neil Austrian Jr. c/o Vinci Pharmaceuticals, Inc. 12 Washington Avenue Avon by the Sea NJ NEW JERSEY 07717 Director Other Health Care Decline to Disclose 06b false 2026-01-02 false true true true false 0 SUPERVISION PARTNERS LLC 300528 None None 641 LEXINGTON AVENUE FL 17 NEW YORK NY NEW YORK 10022 FL FLORIDA IL ILLINOIS true THIRD SEVEN CAPITAL, LLC 160209 None None 67 HOLLY HILL LANE SUITE 300C GREENWICH CT CONNECTICUT 06830 NH NEW HAMPSHIRE NJ NEW JERSEY SC SOUTH CAROLINA false 25348339 20218331 5130008 false 53 117248 true 0 0 false Vinci Pharmaceuticals, Inc. /s/ Philip Gioia Philip Gioia Chief Executive Officer 2026-01-26